Literature DB >> 11834222

Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects.

Vijctor Sanchez-Margalet1, Miguel Valle, Francisco J. Ruz, Felix Gascon, Joaquijn Mateo, Raimundo Goberna.   

Abstract

Homocysteine has been associated with the oxidative stress in the pathogenesis of atherosclerosis. Oxidative stress caused by triglycerides and free fatty acids is known to cause insulin resistance and hyperinsulinemia. On the other hand, insulin resistance may increase homocysteine levels. Since obesity is associated with insulin resistance and hyperinsulinemia, we aimed to study the possible association of homocysteine with hyperinsulinemia in obese subjects. 20 obese male subjects (body mass index >29), aged 33--55 (mean 45 years old) were studied. A fasting blood sample was obtained for the study and the subjects undertook an oral glucose tolerance test with samples taken at 1 and 2 h after glucose. Subjects were divided in two groups according to the fasting insulin levels, < 9 &amp;mgr;U/ml or normoinsulinemic (group 1) and >9 &amp;mgr;U/ml or hyperinsulinemic (group 2). Glucose, insulin, homocysteine, folate, B(12,) total cholesterol, HDL-cholesterol and triglycerides levels were determined in fasting blood samples. In oral glucose tolerance test, glucose, insulin and homocysteine levels were measured. Hyperinsulinemic obese subjects (group 2) had higher levels of insulin and glucose at 1 h and 2 h postglucose, compared with group 1. Fasting total homocysteine and triglyceride levels were also increased in this group, whereas folate and B(12) levels were similar in both groups. Fasting homocysteine significantly correlated with fasting insulin (r = 0.6, p <0.01). Homocysteine levels slightly but significantly decreased after glucose loading in normoinsulinemic but not in hyperinsulinemic obese subjects. These results show that higher homocysteine levels are observed in the hyperinsulinemic obese subjects and suggest that homocysteine could play a role in the higher risk of cardiovascular disease in obesity.

Entities:  

Year:  2002        PMID: 11834222     DOI: 10.1016/s0955-2863(01)00197-8

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  17 in total

1.  Plasma total homocysteine level and its association with carotid intima-media thickness in obesity.

Authors:  O Uysal; E Arikan; B Cakir
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

2.  Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes.

Authors:  G T Russo; A Di Benedetto; E Alessi; R Ientile; A Antico; G Nicocia; R La Scala; E Di Cesare; G Raimondo; D Cucinotta
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

3.  Nutritional regulation of insulin secretion: implications for diabetes.

Authors:  Philip Newsholme; Mauricio Krause
Journal:  Clin Biochem Rev       Date:  2012-05

4.  Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome.

Authors:  Gideon R Hajer; Yolanda van der Graaf; Jobien K Olijhoek; Marianne C Verhaar; Frank L J Visseren
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

5.  Plasma homocysteine as a risk factor for strokes in ghanaian adults.

Authors:  Ak Akpalu; Pk Nyame
Journal:  Ghana Med J       Date:  2009-12

6.  Adropin is associated with hyperhomocysteine and coronary atherosclerosis.

Authors:  Liang-Ping Zhao; Tao You; Siew-Pang Chan; Jian-Chang Chen; Wei-Ting Xu
Journal:  Exp Ther Med       Date:  2015-12-23       Impact factor: 2.447

Review 7.  Insulin resistance, metabolic stress, and atherosclerosis.

Authors:  Meghana Pansuria; Hang Xi; Le Li; Xiao-Feng Yang; Hong Wang
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

8.  MTHFR C677T polymorphism is associated with hyperlipidemia in women with polycystic ovary syndrome.

Authors:  Madhu Jain; Priyanka Pandey; Narendra K Tiwary; Shuchi Jain
Journal:  J Hum Reprod Sci       Date:  2012-01

9.  Homocysteine levels in patients with schizophrenia on clozapine monotherapy.

Authors:  Adam Wysokiński; Iwona Kłoszewska
Journal:  Neurochem Res       Date:  2013-07-20       Impact factor: 3.996

10.  Prevalence and clinical demography of hyperhomocysteinemia in Han Chinese patients with schizophrenia.

Authors:  Yating Yang; Juan Wang; Zulun Xiong; Xianhu Yao; Yulong Zhang; Xiaoshuai Ning; Yi Zhong; Zhiwei Liu; Yelei Zhang; Tongtong Zhao; Lei Xia; Kai Zhang; Huanzhong Liu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-06-08       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.